| 000 | 01497 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250512014225.0 | ||
| 264 | 0 | _c19890621 | |
| 008 | 198906s 0 0 eng d | ||
| 022 | _a0143-5221 | ||
| 024 | 7 |
_a10.1042/cs0760377 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAcheson, D W | |
| 245 | 0 | 0 |
_aFactors contributing to the accelerated clearance of theophylline and antipyrine in adults with exocrine pancreatic disease. _h[electronic resource] |
| 260 |
_bClinical science (London, England : 1979) _cApr 1989 |
||
| 300 |
_a377-85 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAlcohol Drinking |
| 650 | 0 | 4 |
_aAntipyrine _xpharmacokinetics |
| 650 | 0 | 4 | _aEnzyme Induction |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aPancreatic Diseases _xmetabolism |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xmetabolism |
| 650 | 0 | 4 |
_aPancreatitis _xetiology |
| 650 | 0 | 4 | _aSmoking |
| 650 | 0 | 4 |
_aTheophylline _xpharmacokinetics |
| 700 | 1 | _aHunt, L P | |
| 700 | 1 | _aRose, P | |
| 700 | 1 | _aHouston, J B | |
| 700 | 1 | _aBraganza, J M | |
| 773 | 0 |
_tClinical science (London, England : 1979) _gvol. 76 _gno. 4 _gp. 377-85 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1042/cs0760377 _zAvailable from publisher's website |
| 999 |
_c2719926 _d2719926 |
||